These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34082425)

  • 41. Intranasal antihistamine is superior to oral H
    Du K; Qing H; Zheng M; Wang X; Zhang L
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):589-596.e3. PubMed ID: 32650045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis.
    Yáñez A; Rodrigo GJ
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):479-84. PubMed ID: 12452206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of Intranasal Corticosteroid Sensory Attributes and Patient Preference for Fluticasone Furoate for the Treatment of Allergic Rhinitis.
    May JR; Dolen WK
    Clin Ther; 2019 Aug; 41(8):1589-1596. PubMed ID: 31402060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Azelastine hydrochloride: a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability.
    Bernstein JA
    Curr Med Res Opin; 2007 Oct; 23(10):2441-52. PubMed ID: 17723160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.
    Carr W; Bernstein J; Lieberman P; Meltzer E; Bachert C; Price D; Munzel U; Bousquet J
    J Allergy Clin Immunol; 2012 May; 129(5):1282-1289.e10. PubMed ID: 22418065
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis.
    Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C
    Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.
    Meltzer E; Ratner P; Bachert C; Carr W; Berger W; Canonica GW; Hadley J; Lieberman P; Hampel FC; Mullol J; Munzel U; Price D; Scadding G; Virchow JC; Wahn U; Murray R; Bousquet J
    Int Arch Allergy Immunol; 2013; 161(4):369-77. PubMed ID: 23652808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.
    Bachert C; Bousquet J; Hellings P
    Clin Transl Allergy; 2018; 8():25. PubMed ID: 29983907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.
    Klimek L; Bachert C; Mösges R; Munzel U; Price D; Virchow JC; Wahn U; Bousquet J
    Allergy Asthma Proc; 2015; 36(1):40-7. PubMed ID: 25562555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis.
    Kaszuba SM; Baroody FM; deTineo M; Haney L; Blair C; Naclerio RM
    Arch Intern Med; 2001 Nov; 161(21):2581-7. PubMed ID: 11718589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Comparative Study of Montelukast and Azelastine add on Therapy in Moderate to Severe Allergic Rhinitis Treatment: A Double-Blind Randomized Clinical Trial.
    Esmaeilzadeh H; Far NM; Nabavizadeh SH; Babaeian M; Hadipour M; Alyasin S
    Am J Rhinol Allergy; 2022 Sep; 36(5):559-567. PubMed ID: 35300506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis.
    Feng S; Fan Y; Liang Z; Ma R; Cao W
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3477-3486. PubMed ID: 26545381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis.
    Falser N; Wober W; Rahlfs VW; Baehre M
    Arzneimittelforschung; 2001; 51(5):387-93. PubMed ID: 11413739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.
    Bjermer L; Westman M; Holmström M; Wickman MC
    Allergy Asthma Clin Immunol; 2019; 15():24. PubMed ID: 31015846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel and effective approach to treating rhinitis with nasal antihistamines.
    Kaliner MA
    Ann Allergy Asthma Immunol; 2007 Nov; 99(5):383-90; quiz 391-2, 418. PubMed ID: 18051206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal azelastine. A review of its efficacy in the management of allergic rhinitis.
    McNeely W; Wiseman LR
    Drugs; 1998 Jul; 56(1):91-114. PubMed ID: 9664202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of Allergic Rhinitis: A Review for the Community Pharmacist.
    May JR; Dolen WK
    Clin Ther; 2017 Dec; 39(12):2410-2419. PubMed ID: 29079387
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray.
    Derendorf H; Munzel U; Petzold U; Maus J; Mascher H; Hermann R; Bousquet J
    Br J Clin Pharmacol; 2012 Jul; 74(1):125-33. PubMed ID: 22356350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.